Enhancing engraftment of islets using perioperative sodium 4-phenylbutyrate

International Immunopharmacology

Volumn 6, Issue 13-14, 2006, Pages 1952-1959

  Hsu, Brend Ray Sea ^a   Chen, Szu Tah ^a   Fu, Shin Huei ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Engraftment; Interleukin 1 beta; Islet of Langerhans; Phenylbutyrate; Primary nonfunction

Indexed keywords

4 PHENYLBUTYRIC ACID; CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 1BETA; LEUKOTRIENE B4; NITRIC OXIDE; NITROGEN DIOXIDE; PROSTAGLANDIN E2; PROSTAGLANDIN J2; SODIUM CHLORIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; ISOGRAFT; MALE; MOUSE; NONHUMAN; PANCREAS FUNCTION; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PERIOPERATIVE PERIOD; PRIMARY NONFUNCTION; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; GRAFT SURVIVAL; INSULIN; INTERLEUKIN-1BETA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LEUKOTRIENE B4; MALE; MICE; MICE, INBRED C57BL; NITRATES; NITRITES; PANCREAS; PHENYLBUTYRATES; PROSTAGLANDINS;

EID: 33845221214     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.09.012     Document Type: Article

References (25)

1. Biarnes M., Montolio M., Nacher V., Raurell M., Soler J., and Montanya E. β-Cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 51 (2002) 66-72
2. Burkart V., and Kolb H. Protection of islet cells from inflammatory cell death in vitro. Clin Exp Immunol 93 (1993) 273-278
3. Gysemans C., Stoffels K., Giulietti A., Overbergh L., Waer M., Lannoo M., et al. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents. Diabetologia 46 (2003) 1115-1123
4. Kaufman D.B., Gores P.F., Field M.J., Farney A.C., Gruber S.A., Stephanian E., et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43 (1994) 778-783
5. Hsu B.R.S., Juang J.H., Fu S.H., Kuo C.H., and Lu W.T. Reduction in primary nonfunction of syngeneic islet transplants with nordihydroguaiaretic acid, a lipoxygenase inhibitor. Cell Transplant 10 (2001) 255-262
6. Pinto A., Fidalgo P., Cravo M., Midoes J., Chaves P., Rosa J., et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis: randomized, double-blind, controlled trial. Dis Colon Rectum 42 (1999) 788-796
7. Segain J.P., Raingeard de la Blétière D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NFkB inhibition: implications for Crohn's disease. Gut 47 (2000) 397-403
8. Steinhart A.H., Brzezinski A., and Baker J.P. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 89 (1994) 179-183
9. Kvale D., and Brandtzaeg P. Constitutive and cytokine induced expression of HLA molecules, secretory component, and intercellular adhesion molecule-1 is modulated by butyrate in the colonic epithelial cell line HT-29. Gut 36 (1995) 737-742
10. Lührs H., Gerke T., Boxberger F., Backhaus K., Melcher R., Scheppach W., et al. Butyrate inhibits interleukin-1-mediated nuclear factor-kappa B activation in human epithelial cells. Dig Dis Sci 46 (2001) 1968-1973
11. Lührs H., Gerke T., Schauber J., Dusel G., Melcher R., Scheppach W., et al. Cytokine-activated degradation of inhibitory κB protein α is inhibited by the short-chain fatty acid butyrate. Int J Colorectal Dis 16 (2001) 195-201
12. Burlina A.B., Ogier H., Korall H., and Trefz F.K. Long-term treatment with sodium phenylbutyrate in ornithine transcarbamylase-deficient patients. Mol Genet Metab 72 (2001) 351-355
13. Collins A.F., Pearson H.A., Giardina P., McDonagh K.T., Brusilow S.W., and Dover G.J. Oral sodium phenylbutyrate therapy in homozygous β thalassemia: a clinical trial. Blood 85 (1995) 43-49
14. Gore S.D., Weng L.J., Zhai S., Figg W.D., Donehower R.C., Dover G.J., et al. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Clin Cancer Res 7 (2001) 2330-2339
15. MacMillan M.L., Fouladi M., Nisbet-Brown E., Waye J.S., and Olivieri N.F. Treatment of two infants with Cooley's anemia with sodium phenylbutyrate. Ann NY Acad Sci 850 (1998) 452-454
16. Pili R., Kruszewski M.P., Hager B.W., Lantz J., and Carducci M.A. Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis. Cancer Res 61 (2001) 1477-1485
17. Yu K.H., Weng L.J., Fu S., Piantadosi S., and Gore S.D. Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoid acid. Leukemia 13 (1999) 1258-1265
18. Juang J.H., Hsu B.R., Kuo C.H., and Uengt S.W. Beneficial effects of hyperbaric oxygen therapy on islet transplantation. Cell Transplant 11 (2002) 95-101
19. Overbergh L., Valckx D., Waer M., and Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 11 (1999) 305-312
20. Singer V.L., Jones L.J., Yue S.T., and Haugland R.P. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA. Anal Biochem 249 (1997) 228-238
21. McCulloch D.K., Koerker D.J., Kahn S.E., Bonner-Weir S., and Palmer J.P. Correlations of in vivo β-cell function tests with β-cell mass and pancreatic insulin content in streptozocin-administered baboons. Diabetes 40 (1991) 673-679
22. Maedler K., Sergeev P., Ris F., Oberholzer J., Joller-Jemelka H.I., Spinas G.A., et al. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110 (2002) 851-860
23. Weringer E.J., Perry B.D., Sawyer P.S., Gilman S.C., and Showell H.J. Antagonizing leukotriene B4 receptors delays cardiac allograft rejection in mice. Transplantation 67 (1999) 808-815
24. Mollace V., Muscoli C., Masini E., Cuzzocrea S., and Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57 (2005) 217-252
25. Shapiro A.M., Lakey J.R., Ryan E.A., Korbutt G.S., Toth E., Warnock G.L., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 (2000) 289-290